Journal Article

The G1 domain of aggrecan released from porcine articular cartilage forms stable complexes with hyaluronan/link protein

T. Yasumoto, J. L. E. Bird, K. Sugimoto, R. M. Mason and M. T. Bayliss

in Rheumatology

Volume 42, issue 2, pages 336-342
Published in print February 2003 | ISSN: 1462-0324
Published online February 2003 | e-ISSN: 1462-0332 | DOI: https://dx.doi.org/10.1093/rheumatology/keg109
The G1 domain of aggrecan released from porcine articular cartilage forms stable complexes with hyaluronan/link protein

Show Summary Details

Preview

Objective. To raise peptide antibodies recognizing the C‐terminal amino acid sequence in the G1 domain of porcine aggrecan, generated by the action of either aggrecanase or neutral metalloproteinase(s), in rabbits and to use them to investigate the release of aggrecan from porcine articular cartilage.

Method. An explant culture system was used to investigate the release of the G1 domain of aggrecan from porcine articular cartilage treated with retinoic acid or interleukin 1β and to study how the activity of these agents is modified by the proteinase inhibitor, batimastat (BB94).

Results. Retinoic acid and interleukin 1β induced both enzyme activities and the release of the G1 domain into the culture medium. Proteinase activity was significantly reduced when the tissue was incubated in the presence of BB94. The functional properties of the enzyme‐generated G1 domain were studied using large‐pore, agarose/polyacrylamide gel electrophoresis, and it was shown to interact with hyaluronan and link protein.

Conclusions. The results show that there must be a mechanism for removing a functional G1 domain from aggrecan during tissue turnover using this culture system.

Keywords: Cartilage; Aggrecanase; Metalloproteinase; Aggrecan; Neo‐epitopes.

Journal Article.  4446 words.  Illustrated.

Subjects: Rheumatology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or purchase to access all content.